Hand-foot syndrome

The European Commission ( EC ) has approved Fotivda ( Tivozanib ) for the treatment of adult patients with advanced...


The FDA ( Food and Drug Administration ) granted Priority Review in metastatic melanoma for the supplemental New Drug Application...



Prolonging first-line chemotherapy results with maintenance treatment may influence overall survival. In HER2-negative patients with locally recurrent/metastatic breast cancer, combining...


The Food and Drug Administration ( FDA ) has approved two new drugs, Tafinlar ( Dabrafenib ) and Mekinist (...


Stivarga is an anticancer medicine that contains the active substance Regorafenib. It is used to treat metastatic colorectal cancer in...


Pazopanib ( Votrient ) and Sunitinib ( Sutent ) provided a progression-free survival benefit, as compared with placebo or Interferon,...


The results from the randomized phase II PRECEDENT trial for Vintafolide, an investigational folate small molecule drug conjugate ( SMDC...


The results of a phase III study ( Study 301 ) of Eribulin mesylate ( Halaven ) versus Capecitabine (...


The FDA ( Food and Drug Administration ) has approved Tykerb ( Lapatinib ), a new targeted anti-cancer treatment, to...


A Phase III study has shown that Lapatinib ( Tykerb ) and Capecitabine ( Xeloda ) versus Capecitabine alone nearly...


A Phase III study has shown that Lapatinib ( Tykerb ) and Capecitabine ( Xeloda ) versus Capecitabine alone nearly...